HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-03-30FDA Approved: ABACAVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for abacavir from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2023-03-28Clinical Trial Update: Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women [Phase 3]
Phase 3 trial update comparing long-acting injectable cabotegravir with daily oral TDF/FTC for HIV pre-exposure prophylaxis in HIV-uninfecte…
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: The Risk of HIV Acquisition Among Traditional Healers in South Africa [NA]
This completed clinical trial evaluated the risk of HIV infection among traditional healers in South Africa, with results posted in March 20…
-
EMA withdrawal · 2023-03-21EMA Withdrawn: Nevirapine Teva (nevirapine) — Teva B.V.
EMA withdrew Nevirapine Teva (nevirapine) from the market; HIV infections was the therapeutic area.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016) [Phase 2]
This is a Phase 2 update on the safety and pharmacokinetics of once-monthly oral islatravir (MK-8591). The MK-8591-016 trial studied partici…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Change the Cycle: An RCT to Prevent Injection Initiation [NA]
An RCT evaluating strategies to prevent initiation of injection use in individuals, completed with posted results in 2023.
-
CLINICAL_TRIALS research · 2023-03-16Clinical Trial Update: Evaluation of Pre-exposure Prophylaxis Cascade in Pregnant and Breastfeeding Women in Cape Town (Formative Study) [Phase 4]
A Phase 4 formative study evaluating the pre-exposure prophylaxis cascade in pregnant and breastfeeding women in Cape Town, completing with …
-
CLINICAL_TRIALS trial_result · 2023-03-15Clinical Trial Update: Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults [Phase 3]
Phase 3 trial comparing Bictegravir/Emtricitabine/Tenofovir Alafenamide to a Dolutegravir-based regimen in treatment-naive adults co-infecte…
-
FDA approval · 2023-03-15FDA Approved: EMTRICITABINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for emtricitabine from Aurobindo Pharma Limited (ANDA).
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa [Phase 3]
A Phase 3 clinical trial update for early empiric anti-tuberculosis therapy in sepsis patients in Sub-Saharan Africa is reported as status u…
-
FDA approval · 2023-03-09FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's generic fixed-dose combination emtricitabine and tenofovir disoproxil fumarate for HIV-1 infection v…
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke [Phase 3]
A Phase 3 trial investigating strategies to optimize smoking cessation in people living with HIV/AIDS has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated Brentuximab Vedotin in combination chemotherapy for AIDS-related Hodgkin lymphoma in HIV-infected pati…
-
EMA approval · 2023-03-03EMA Authorised: Efavirenz Teva (efavirenz) — Teva B.V.
EFAVIRZEN Teva has been authorised in the EU for HIV infection treatment.
-
FDA approval · 2023-02-27FDA Approved: VOCABRIA — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for VOCABRIA (cabotegravir sodium) filed by ViiV Healthcare Company. The action updates the labeling…
-
FDA approval · 2023-02-27FDA Approved: CABENUVA — Supplemental Application (ViiV Healthcare Company)
The FDA approved a supplemental application for CABENUVA, the long-acting HIV-1 treatment regimen of cabotegravir and rilpivirine, filed by …
-
FDA approval · 2023-02-27FDA Approved: APRETUDE — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for APRETUDE (cabotegravir) by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Doravirine/Islatravir (DOR/ISL) in Pediatric Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are <18 Years of Age and Weigh ≥35 kg (MK-8591A-028) [Phase 2]
Phase 2 pediatric trial update for Doravirine/Islatravir in children under 18 years weighing at least 35 kg with HIV-1; study completed with…
-
CLINICAL_TRIALS trial_result · 2023-02-23Clinical Trial Update: A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM [NA]
A pragmatic clinical trial evaluating MyPEEPS Mobile to improve HIV prevention behaviors in diverse adolescent men who have sex with men has…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Gardasil Immunogenicity With Needle-Free Injection [Phase 2]
Phase 2 trial update evaluating immunogenicity of Gardasil delivered by a needle-free injection in HIV-related conditions has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: A Proof-of-concept Trial to Evaluate the Safety and Efficacy of UB-421 Plus Chidamide in Changing HIV Reservoirs [Phase 2]
Phase 2 proof-of-concept trial evaluating UB-421 plus chidamide for safety and efficacy in changing HIV reservoirs has completed.
-
EMA approval · 2023-02-14EMA Authorised: Tybost (cobicistat) — Gilead Sciences Ireland UC
Authorisation of Tybost (cobicistat) by EMA for use in HIV infections.
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: Dual bNAb Treatment in Children [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a dual broadly neutralizing antibody (bNAb) treatment for HIV infection in children has completed enro…
-
CLINICAL_TRIALS research · 2023-02-10Clinical Trial Update: Universal HIV Screening and Targeted HCV Screening in Emergency Department [NA]
A completed clinical trial evaluating universal HIV and targeted HCV screening in emergency departments, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa [Phase 2, Phase 3]
Pivotal Phase 2b/3 trial in South Africa evaluates the safety and efficacy of an ALVAC-based HIV vaccine with bivalent gp120 and MF59 adjuva…